Cargando…

Gametocyte clearance in children, from western Kenya, with uncomplicated Plasmodium falciparum malaria after artemether–lumefantrine or dihydroartemisinin–piperaquine treatment

BACKGROUND: The efficacy and safety of artemether–lumefantrine (AL) and dihydroartemisinin–piperaquine (DP) against asexual parasites population has been documented. However, the effect of these anti-malarials on sexual parasites is still less clear. Gametocyte clearance following treatment is essen...

Descripción completa

Detalles Bibliográficos
Autores principales: Omondi, Protus, Burugu, Marion, Matoke-Muhia, Damaris, Too, Edwin, Nambati, Eva A., Chege, William, Musyoka, Kelvin B., Thiongo, Kelvin, Otinga, Maureen, Muregi, Francis, Kimani, Francis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891957/
https://www.ncbi.nlm.nih.gov/pubmed/31801562
http://dx.doi.org/10.1186/s12936-019-3032-3
_version_ 1783475932592340992
author Omondi, Protus
Burugu, Marion
Matoke-Muhia, Damaris
Too, Edwin
Nambati, Eva A.
Chege, William
Musyoka, Kelvin B.
Thiongo, Kelvin
Otinga, Maureen
Muregi, Francis
Kimani, Francis
author_facet Omondi, Protus
Burugu, Marion
Matoke-Muhia, Damaris
Too, Edwin
Nambati, Eva A.
Chege, William
Musyoka, Kelvin B.
Thiongo, Kelvin
Otinga, Maureen
Muregi, Francis
Kimani, Francis
author_sort Omondi, Protus
collection PubMed
description BACKGROUND: The efficacy and safety of artemether–lumefantrine (AL) and dihydroartemisinin–piperaquine (DP) against asexual parasites population has been documented. However, the effect of these anti-malarials on sexual parasites is still less clear. Gametocyte clearance following treatment is essential for malaria control and elimination efforts; therefore, the study sought to determine trends in gametocyte clearance after AL or DP treatment in children from a malaria-endemic site in Kenya. METHODS: Children aged between 0.5 and 12 years from Busia, western Kenya with uncomplicated Plasmodium falciparum malaria were assigned randomly to AL or DP treatment. A total of 334 children were enrolled, and dried blood spot samples were collected for up to 6 weeks after treatment during the peak malaria transmission season in 2016 and preserved. Plasmodium falciparum gametocytes were detected by qRT-PCR and gametocyte prevalence, density and mean duration of gametocyte carriage were determined. RESULTS: At baseline, all the 334 children had positive asexual parasites by microscopy, 12% (40/334) had detectable gametocyte by microscopy, and 83.7% (253/302) children had gametocytes by RT-qPCR. Gametocyte prevalence by RT-qPCR decreased from 85.1% (126/148) at day 0 to 7.04% (5/71) at day 42 in AL group and from 82.4% (127/154) at day 0 to 14.5% (11/74) at day 42 in DP group. The average duration of gametocyte carriage as estimated by qRT-PCR was slightly shorter in the AL group (4.5 days) than in the DP group (5.1 days) but not significantly different (p = 0.301). CONCLUSION: The study identifies no significant difference between AL and DP in gametocyte clearance. Gametocytes persisted up to 42 days post treatment in minority of individuals in both treatment arms. A gametocytocidal drug, in combination with artemisinin-based combination therapy, will be useful in blocking malaria transmission more efficiently.
format Online
Article
Text
id pubmed-6891957
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68919572019-12-11 Gametocyte clearance in children, from western Kenya, with uncomplicated Plasmodium falciparum malaria after artemether–lumefantrine or dihydroartemisinin–piperaquine treatment Omondi, Protus Burugu, Marion Matoke-Muhia, Damaris Too, Edwin Nambati, Eva A. Chege, William Musyoka, Kelvin B. Thiongo, Kelvin Otinga, Maureen Muregi, Francis Kimani, Francis Malar J Research BACKGROUND: The efficacy and safety of artemether–lumefantrine (AL) and dihydroartemisinin–piperaquine (DP) against asexual parasites population has been documented. However, the effect of these anti-malarials on sexual parasites is still less clear. Gametocyte clearance following treatment is essential for malaria control and elimination efforts; therefore, the study sought to determine trends in gametocyte clearance after AL or DP treatment in children from a malaria-endemic site in Kenya. METHODS: Children aged between 0.5 and 12 years from Busia, western Kenya with uncomplicated Plasmodium falciparum malaria were assigned randomly to AL or DP treatment. A total of 334 children were enrolled, and dried blood spot samples were collected for up to 6 weeks after treatment during the peak malaria transmission season in 2016 and preserved. Plasmodium falciparum gametocytes were detected by qRT-PCR and gametocyte prevalence, density and mean duration of gametocyte carriage were determined. RESULTS: At baseline, all the 334 children had positive asexual parasites by microscopy, 12% (40/334) had detectable gametocyte by microscopy, and 83.7% (253/302) children had gametocytes by RT-qPCR. Gametocyte prevalence by RT-qPCR decreased from 85.1% (126/148) at day 0 to 7.04% (5/71) at day 42 in AL group and from 82.4% (127/154) at day 0 to 14.5% (11/74) at day 42 in DP group. The average duration of gametocyte carriage as estimated by qRT-PCR was slightly shorter in the AL group (4.5 days) than in the DP group (5.1 days) but not significantly different (p = 0.301). CONCLUSION: The study identifies no significant difference between AL and DP in gametocyte clearance. Gametocytes persisted up to 42 days post treatment in minority of individuals in both treatment arms. A gametocytocidal drug, in combination with artemisinin-based combination therapy, will be useful in blocking malaria transmission more efficiently. BioMed Central 2019-12-04 /pmc/articles/PMC6891957/ /pubmed/31801562 http://dx.doi.org/10.1186/s12936-019-3032-3 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Omondi, Protus
Burugu, Marion
Matoke-Muhia, Damaris
Too, Edwin
Nambati, Eva A.
Chege, William
Musyoka, Kelvin B.
Thiongo, Kelvin
Otinga, Maureen
Muregi, Francis
Kimani, Francis
Gametocyte clearance in children, from western Kenya, with uncomplicated Plasmodium falciparum malaria after artemether–lumefantrine or dihydroartemisinin–piperaquine treatment
title Gametocyte clearance in children, from western Kenya, with uncomplicated Plasmodium falciparum malaria after artemether–lumefantrine or dihydroartemisinin–piperaquine treatment
title_full Gametocyte clearance in children, from western Kenya, with uncomplicated Plasmodium falciparum malaria after artemether–lumefantrine or dihydroartemisinin–piperaquine treatment
title_fullStr Gametocyte clearance in children, from western Kenya, with uncomplicated Plasmodium falciparum malaria after artemether–lumefantrine or dihydroartemisinin–piperaquine treatment
title_full_unstemmed Gametocyte clearance in children, from western Kenya, with uncomplicated Plasmodium falciparum malaria after artemether–lumefantrine or dihydroartemisinin–piperaquine treatment
title_short Gametocyte clearance in children, from western Kenya, with uncomplicated Plasmodium falciparum malaria after artemether–lumefantrine or dihydroartemisinin–piperaquine treatment
title_sort gametocyte clearance in children, from western kenya, with uncomplicated plasmodium falciparum malaria after artemether–lumefantrine or dihydroartemisinin–piperaquine treatment
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891957/
https://www.ncbi.nlm.nih.gov/pubmed/31801562
http://dx.doi.org/10.1186/s12936-019-3032-3
work_keys_str_mv AT omondiprotus gametocyteclearanceinchildrenfromwesternkenyawithuncomplicatedplasmodiumfalciparummalariaafterartemetherlumefantrineordihydroartemisininpiperaquinetreatment
AT burugumarion gametocyteclearanceinchildrenfromwesternkenyawithuncomplicatedplasmodiumfalciparummalariaafterartemetherlumefantrineordihydroartemisininpiperaquinetreatment
AT matokemuhiadamaris gametocyteclearanceinchildrenfromwesternkenyawithuncomplicatedplasmodiumfalciparummalariaafterartemetherlumefantrineordihydroartemisininpiperaquinetreatment
AT tooedwin gametocyteclearanceinchildrenfromwesternkenyawithuncomplicatedplasmodiumfalciparummalariaafterartemetherlumefantrineordihydroartemisininpiperaquinetreatment
AT nambatievaa gametocyteclearanceinchildrenfromwesternkenyawithuncomplicatedplasmodiumfalciparummalariaafterartemetherlumefantrineordihydroartemisininpiperaquinetreatment
AT chegewilliam gametocyteclearanceinchildrenfromwesternkenyawithuncomplicatedplasmodiumfalciparummalariaafterartemetherlumefantrineordihydroartemisininpiperaquinetreatment
AT musyokakelvinb gametocyteclearanceinchildrenfromwesternkenyawithuncomplicatedplasmodiumfalciparummalariaafterartemetherlumefantrineordihydroartemisininpiperaquinetreatment
AT thiongokelvin gametocyteclearanceinchildrenfromwesternkenyawithuncomplicatedplasmodiumfalciparummalariaafterartemetherlumefantrineordihydroartemisininpiperaquinetreatment
AT otingamaureen gametocyteclearanceinchildrenfromwesternkenyawithuncomplicatedplasmodiumfalciparummalariaafterartemetherlumefantrineordihydroartemisininpiperaquinetreatment
AT muregifrancis gametocyteclearanceinchildrenfromwesternkenyawithuncomplicatedplasmodiumfalciparummalariaafterartemetherlumefantrineordihydroartemisininpiperaquinetreatment
AT kimanifrancis gametocyteclearanceinchildrenfromwesternkenyawithuncomplicatedplasmodiumfalciparummalariaafterartemetherlumefantrineordihydroartemisininpiperaquinetreatment